Invention Grant
US07642290B2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
有权
用于治疗自身免疫性疾病，免疫过敏性疾病和器官或组织移植排斥的化合物
- Patent Title: Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
- Patent Title (中): 用于治疗自身免疫性疾病，免疫过敏性疾病和器官或组织移植排斥的化合物
-
Application No.: US10530116Application Date: 2003-10-01
-
Publication No.: US07642290B2Publication Date: 2010-01-05
- Inventor: Eliahu Kaplan
- Applicant: Eliahu Kaplan
- Applicant Address: IL Tel-Aviv
- Assignee: Novaremed Limited
- Current Assignee: Novaremed Limited
- Current Assignee Address: IL Tel-Aviv
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi
- International Application: PCT/IB03/04993 WO 20031001
- International Announcement: WO2004/031129 WO 20040415
- Main IPC: A61K31/165
- IPC: A61K31/165 ; C07C233/16 ; C07C233/23
Abstract:
The present invention provides compounds, pharmaceutical compositions and methods for treating, immuno-allergical diseases, autoimmune diseases, and organ or tissue rejection following transplantation.
Public/Granted literature
Information query
